The coronavirus disease 2019 (COVID-19) is currently representing a global health threat
especially for fragile individuals, such as cancer patients. It was demonstrated that cancer …

The severe acute respiratory syndrome associated coronavirus-2 (SARS-CoV-2) poses a
threat to human life worldwide. Since early March, 2020, coronavirus disease 2019 (COVID …

Background Accumulating evidence showed that regulating tumor microenvironment plays a
vital role in improving antitumor efficiency. Programmed Death Ligand 1 (PD-L1) is …

Nanoparticles can provide effective control of the release rate and tissue distribution of their
drug payload, leading to major pharmacokinetic and pharmacodynamic changes vis-à-vis …

Background: The efficacy of PD-1 or PD-L1 inhibitors in patients with brain metastases of
non-small-cell lung cancer (BM-NSCLC) is inconclusive. Materials & methods: An electronic …

Advances in the development of modern cancer immunotherapy and immune checkpoint
inhibitors have dramatically changed the landscape of cancer treatment. However, most …

People at high risk of morbidity and mortality from coronavirus disease 2019 (COVID-19),
including patients dealing with malignancies and patients on immunosuppressive …

Encapsulation of Doxorubicin (Dox), a potent cytotoxic agent and immunogenic cell death
inducer, in pegylated (Stealth) liposomes, is well known to have major pharmacologic …

Liver cancer cells evade immune surveillance and anticancer response through various
pathways, including the programmed death-ligand 1 (PD-L1)/programmed death-1 (PD-1) …

Gynecologic cancers are a significant health issue for women globally. Early detection and
successful treatment of these tumors are crucial for the survival of female patients …